Home
UTHR
UTHR News

Latest United Therapeutics Corporation (UTHR) News on October 10, 2025

What Catalysts Are Reshaping the Narrative for United Therapeutics This Year?

Simply Wall St.

6 days ago

What Catalysts Are Reshaping the Narrative for United Therapeutics This Year?

How Investors Are Reacting To United Therapeutics (UTHR) Positive Phase 3 Results for Tyvaso in IPF

Simply Wall St.

7 days ago

How Investors Are Reacting To United Therapeutics (UTHR) Positive Phase 3 Results for Tyvaso in IPF

Is IPF the Next Big Market Opportunity for United Therapeutics?

Zacks

9 days ago

Is IPF the Next Big Market Opportunity for United Therapeutics?

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks

9 days ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

MT Newswires

9 days ago

United Therapeutics Insider Sold Shares Worth $3,393,884, According to a Recent SEC Filing

MT Newswires

20 days ago

United Therapeutics Insider Sold Shares Worth $747,768, According to a Recent SEC Filing

Business Wire

21 days ago

United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary Fibrosis

1 Momentum Stock to Target This Week and 2 We Brush Off

StockStory

21 days ago

1 Momentum Stock to Target This Week and 2 We Brush Off

3 Big Reasons to Love United Therapeutics (UTHR)

StockStory

21 days ago

3 Big Reasons to Love United Therapeutics (UTHR)

MT Newswires

22 days ago

United Therapeutics Insider Sold Shares Worth $1,601,062, According to a Recent SEC Filing

Liquidia Corporation (LQDA): A Bull Case Theory

Insider Monkey

23 days ago

Liquidia Corporation (LQDA): A Bull Case Theory

Business Wire

24 days ago

United Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum

Business Wire

a month ago

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the European Respiratory Society Congress

MT Newswires

a month ago

United Therapeutics Insider Sold Shares Worth $3,183,777, According to a Recent SEC Filing

Theravance Bio (TBPH) Up 9.8% Since Last Earnings Report: Can It Continue?

Zacks

a month ago

Theravance Bio (TBPH) Up 9.8% Since Last Earnings Report: Can It Continue?

United Therapeutics Price Strength Rating Jumps; Stock Soared 33% Last Week

Investor's Business Daily

a month ago

United Therapeutics Price Strength Rating Jumps; Stock Soared 33% Last Week

Evaluating United Therapeutics After 30% Rally and New FDA Approval in 2025

Simply Wall St.

a month ago

Evaluating United Therapeutics After 30% Rally and New FDA Approval in 2025

MannKind (MNKD): A Fresh Look at Valuation Following New United Therapeutics Deal Expansion

Simply Wall St.

a month ago

MannKind (MNKD): A Fresh Look at Valuation Following New United Therapeutics Deal Expansion

MT Newswires

a month ago

Sector Update: Health Care Stocks Advance Late Afternoon

MT Newswires

a month ago

Sector Update: Health Care Stocks Rise Friday Afternoon

MT Newswires

a month ago

United Therapeutics' Tyvaso Win in IPF Clears Path for More Revenue, Oppenheimer Says

MT Newswires

a month ago

MannKind's Plan of Increasing Revenue Base, Advancing Potential Pipeline Enhances its Value Creation, Oppenheimer Says

MT Newswires

a month ago

Oppenheimer Adjusts Price Target on United Therapeutics to $575 From $510, Maintains Outperform Rating

MT Newswires

a month ago

United Therapeutics Tyvaso Likely to Be Potential Standard of Care in Idiopathic Pulmonary Fibrosis Market, UBS Says

MT Newswires

a month ago

UBS Adjusts Price Target on United Therapeutics to $560 From $415, Maintains Buy Rating

MT Newswires

a month ago

United Therapeutics Insider Sold Shares Worth $9,396,837, According to a Recent SEC Filing

Why MannKind (MNKD) Is Up 11.7% After Expanding Technosphere Partnership With United Therapeutics

Simply Wall St.

a month ago

Why MannKind (MNKD) Is Up 11.7% After Expanding Technosphere Partnership With United Therapeutics

Why Is United Therapeutics (UTHR) Up 11.9% Since Last Earnings Report?

Zacks

a month ago

Why Is United Therapeutics (UTHR) Up 11.9% Since Last Earnings Report?

Business Wire

a month ago

United Therapeutics Corporation to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Should the Expanded Technosphere Partnership With MannKind Shape United Therapeutics’ (UTHR) Investment Outlook?

Simply Wall St.

a month ago

Should the Expanded Technosphere Partnership With MannKind Shape United Therapeutics’ (UTHR) Investment Outlook?

MT Newswires

2 months ago

United Therapeutics Insider Sold Shares Worth $3,396,249, According to a Recent SEC Filing

United Therapeutics Announces World’s First Bioengineered External Liver Treatment in Clinical Study

Insider Monkey

3 months ago

United Therapeutics Announces World’s First Bioengineered External Liver Treatment in Clinical Study

Tempus AI's Data Business Keeps Scaling Up: Can the Growth Pace Last?

Zacks

3 months ago

Tempus AI's Data Business Keeps Scaling Up: Can the Growth Pace Last?

Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term

Zacks

3 months ago

Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

3 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Does United Therapeutics (NASDAQ:UTHR) Deserve A Spot On Your Watchlist?

Simply Wall St.

3 months ago

Does United Therapeutics (NASDAQ:UTHR) Deserve A Spot On Your Watchlist?

5 Must-Read Analyst Questions From United Therapeutics’s Q1 Earnings Call

StockStory

3 months ago

5 Must-Read Analyst Questions From United Therapeutics’s Q1 Earnings Call

Business Wire

4 months ago

United Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered Liver

Business Wire

4 months ago

United Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension

MT Newswires

4 months ago

United Therapeutics Insider Sold Shares Worth $3,079,514, According to a Recent SEC Filing

United Therapeutics (UTHR) Soars 3.5%: Is Further Upside Left in the Stock?

Zacks

4 months ago

United Therapeutics (UTHR) Soars 3.5%: Is Further Upside Left in the Stock?

1 of Wall Street’s Favorite Stock with Exciting Potential and 2 to Keep Off Your Radar

StockStory

4 months ago

1 of Wall Street’s Favorite Stock with Exciting Potential and 2 to Keep Off Your Radar

Argus Research

4 months ago

Stock Market Adjusts to Tariff Turmoil

Insmed Stock Jumps 29% on Encouraging PAH Study Results

Zacks

4 months ago

Insmed Stock Jumps 29% on Encouraging PAH Study Results

Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidia

Investor's Business Daily

4 months ago

Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidia

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks

4 months ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Zacks

4 months ago

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Catalyst (CPRX) Up 11.4% Since Last Earnings Report: Can It Continue?

Zacks

4 months ago

Catalyst (CPRX) Up 11.4% Since Last Earnings Report: Can It Continue?

Corcept (CORT) Down 1.7% Since Last Earnings Report: Can It Rebound?

Zacks

4 months ago

Corcept (CORT) Down 1.7% Since Last Earnings Report: Can It Rebound?

MT Newswires

4 months ago

Liquidia Set to Make First Commercial Shipment of Yutrepia for Pulmonary Hypertension

MT Newswires

4 months ago

Cantor Fitzgerald Initiates United Therapeutics at Overweight With $405 Price Target

Why Is United Therapeutics (UTHR) Up 9% Since Last Earnings Report?

Zacks

4 months ago

Why Is United Therapeutics (UTHR) Up 9% Since Last Earnings Report?

Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

StockStory

4 months ago

Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

Those who invested in United Therapeutics (NASDAQ:UTHR) five years ago are up 151%

Simply Wall St.

4 months ago

Those who invested in United Therapeutics (NASDAQ:UTHR) five years ago are up 151%

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

StockStory

4 months ago

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

1 Safe-and-Steady Stock on Our Buy List and 2 to Ignore

StockStory

5 months ago

1 Safe-and-Steady Stock on Our Buy List and 2 to Ignore

Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses

StockStory

5 months ago

Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses

UTHR Q1 Earnings Call: Double-Digit Growth Continues, Pipeline Expansion Remains Central

StockStory

5 months ago

UTHR Q1 Earnings Call: Double-Digit Growth Continues, Pipeline Expansion Remains Central

MT Newswires

5 months ago

Liquidia Faces Patent Litigation Filed by United Therapeutics

Is United Therapeutics (UTHR) the Best Stock to Buy According to Jim Simons’ Renaissance Technologies?

Insider Monkey

5 months ago

Is United Therapeutics (UTHR) the Best Stock to Buy According to Jim Simons’ Renaissance Technologies?

Liquidia Corp (LQDA) Q1 2025 Earnings Call Highlights: Strategic Advances and Legal Wins Propel ...

GuruFocus.com

5 months ago

Liquidia Corp (LQDA) Q1 2025 Earnings Call Highlights: Strategic Advances and Legal Wins Propel ...

3 Big Reasons to Love United Therapeutics (UTHR)

StockStory

5 months ago

3 Big Reasons to Love United Therapeutics (UTHR)

Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

StockStory

5 months ago

Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

Therapeutics Stocks Q1 Results: Benchmarking Sarepta Therapeutics (NASDAQ:SRPT)

StockStory

5 months ago

Therapeutics Stocks Q1 Results: Benchmarking Sarepta Therapeutics (NASDAQ:SRPT)

3 Market-Beating Stocks with Solid Fundamentals

StockStory

5 months ago

3 Market-Beating Stocks with Solid Fundamentals

Argus Research

5 months ago

Analyst Report: United Therapeutics Corp

Argus Research

5 months ago

Market Digest: CCI, AMP, CMCSA, CME, CVS, ECL, GD, HLF, PFE, PH, UTHR, WDC, PPC

Earnings To Watch: Sarepta Therapeutics (SRPT) Reports Q1 Results Tomorrow

StockStory

5 months ago

Earnings To Watch: Sarepta Therapeutics (SRPT) Reports Q1 Results Tomorrow

United Therapeutics First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

5 months ago

United Therapeutics First Quarter 2025 Earnings: Beats Expectations

UTHR Q1 Earnings & Revenues Beat Estimates on Higher Tyvaso Sales

Zacks

5 months ago

UTHR Q1 Earnings & Revenues Beat Estimates on Higher Tyvaso Sales

United Therapeutics Corp (UTHR) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...

GuruFocus.com

5 months ago

United Therapeutics Corp (UTHR) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...

1 Value Stock Worth Investigating and 2 to Brush Off

StockStory

5 months ago

1 Value Stock Worth Investigating and 2 to Brush Off

Thomson Reuters StreetEvents

5 months ago

Q1 2025 United Therapeutics Corp Earnings Call

United Therapeutics (UTHR) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks

5 months ago

United Therapeutics (UTHR) Reports Q1 Earnings: What Key Metrics Have to Say

United Therapeutics (UTHR) Q1 Earnings and Revenues Top Estimates

Zacks

5 months ago

United Therapeutics (UTHR) Q1 Earnings and Revenues Top Estimates

MT Newswires

5 months ago

United Therapeutics Q1 Earnings, Revenue Rise

United Therapeutics (NASDAQ:UTHR) Reports Bullish Q1

StockStory

5 months ago

United Therapeutics (NASDAQ:UTHR) Reports Bullish Q1

Associated Press Finance

5 months ago

United Therapeutics: Q1 Earnings Snapshot

Business Wire

5 months ago

United Therapeutics Corporation Reports First Quarter 2025 Financial Results

United Therapeutics (UTHR) To Report Earnings Tomorrow: Here Is What To Expect

StockStory

5 months ago

United Therapeutics (UTHR) To Report Earnings Tomorrow: Here Is What To Expect

Neurocrine Biosciences (NBIX) Q1 Earnings Preview: What's in the Cards?

Zacks

5 months ago

Neurocrine Biosciences (NBIX) Q1 Earnings Preview: What's in the Cards?

United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy?

Zacks

6 months ago

United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy?

MT Newswires

6 months ago

BofA Securities Upgrades United Therapeutics to Neutral From Underperform

Business Wire

6 months ago

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2025 International Conference

MT Newswires

6 months ago

United Therapeutics Insider Sold Shares Worth $3,121,543, According to a Recent SEC Filing

Business Wire

6 months ago

United Therapeutics Corporation to Report First Quarter 2025 Financial Results Before Market Open on Wednesday, April 30, 2025

Here's Why United Therapeutics (UTHR) is a Strong Value Stock

Zacks

6 months ago

Here's Why United Therapeutics (UTHR) is a Strong Value Stock

2 of Wall Street’s Favorite Stocks to Target This Week and 1 to Question

StockStory

6 months ago

2 of Wall Street’s Favorite Stocks to Target This Week and 1 to Question

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks

6 months ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Zacks

6 months ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

MT Newswires

6 months ago

United Therapeutics Insider Sold Shares Worth $1,138,200, According to a Recent SEC Filing

Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?

Zacks

6 months ago

Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?

MT Newswires

6 months ago

United Therapeutics Insider Sold Shares Worth $3,367,984, According to a Recent SEC Filing

Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4

StockStory

6 months ago

Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4

Business Wire

6 months ago

United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the International Society for Heart and Lung Transplantation 45th Annual Meeting and Scientific Sessions

Business Wire

6 months ago

United Therapeutics Named to ‘100 Best Companies to Work For’ in 2025 by Fortune Media and Great Place to Work

Is United Therapeutics Corporation (UTHR) The Most Profitable Biotech Stock To Buy Right Now?

Insider Monkey

6 months ago

Is United Therapeutics Corporation (UTHR) The Most Profitable Biotech Stock To Buy Right Now?

Is United Therapeutics (UTHR) The Most Expensive Stock Insiders Are Dumping In March?

Insider Monkey

6 months ago

Is United Therapeutics (UTHR) The Most Expensive Stock Insiders Are Dumping In March?

United Therapeutics (UTHR) Down 4.8% Since Last Earnings Report: Can It Rebound?

Zacks

6 months ago

United Therapeutics (UTHR) Down 4.8% Since Last Earnings Report: Can It Rebound?

Argus Research

6 months ago

The Argus Mid-Cap Model Portfolio

Share on Social Networks: